Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GEIS-27: Phase I/II Multicenter and Prospective Trial of Nilotinib and Adriamycin as Neoadjuvant Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum

NCT02587169 is registered in ClinicalTrials.gov with Broto, Javier Martín, M.D. as lead sponsor.

NCT NCT02587169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02587169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GEIS-27: Phase I/II Multicenter and Prospective Trial of Nilotinib and Adriamycin as Neoadjuvant Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum
Lead sponsor
Broto, Javier Martín, M.D.
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
December 31, 2015
Enrollment
40 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

chondrosarcoma, retroperitoneal leiomyosarcoma, retroperitoneal liposarcoma